US equities |
MU $1,015.39 ▼-2.89% NVDA $237.69 ▼-0.65% AMD $634.86 ▼-2.24% INTC $112.35 ▼-0.13% SPCX $168.96 ▼-1.72% SNDK $1,633.71 ▼-1.61% AAPL $337.92 ▲+1.29% MRVL $278.36 ▼-3.01%
FinancialContent

Latest News about Tzield

Recent news which mentions Tzield

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Tickers AMGN CHRS CYTK IBB
Tags Small Cap CHRS lung cancer
From Benzinga